Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.
Laureys G, Willekens B, Vanopdenbosch L, Deryck O, Selleslag D, D'Haeseleer M, De Becker A, Dubois B, Dierickx D, Perrotta G, De Wilde V, van Pesch V, Straetmans N, Dive D, Beguin Y, Van Wijmeersch B, Theunissen K, Kerre T, Van de Velde A. Laureys G, et al. Acta Neurol Belg. 2018 Jun;118(2):161-168. doi: 10.1007/s13760-018-0905-0. Epub 2018 Mar 13. Acta Neurol Belg. 2018. PMID: 29536270 Free article.
Vascular aspects of multiple sclerosis.
D'haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J. D'haeseleer M, et al. Lancet Neurol. 2011 Jul;10(7):657-66. doi: 10.1016/S1474-4422(11)70105-3. Lancet Neurol. 2011. PMID: 21683931 Review.
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.
Cambron M, Mostert J, D'Hooghe M, Nagels G, Willekens B, Debruyne J, Algoed L, Verhagen W, Hupperts R, Heersema D, De Keyser J; FLUOX-PMS Study Group. Cambron M, et al. Mult Scler. 2019 Nov;25(13):1728-1735. doi: 10.1177/1352458519843051. Epub 2019 Jun 20. Mult Scler. 2019. PMID: 31218911
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. Butzkueven H, et al. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668. doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 32234967 Free PMC article.
Brain age as a surrogate marker for cognitive performance in multiple sclerosis.
Denissen S, Engemann DA, De Cock A, Costers L, Baijot J, Laton J, Penner IK, Grothe M, Kirsch M, D'hooghe MB, D'Haeseleer M, Dive D, De Mey J, Van Schependom J, Sima DM, Nagels G. Denissen S, et al. Eur J Neurol. 2022 Oct;29(10):3039-3049. doi: 10.1111/ene.15473. Epub 2022 Jul 11. Eur J Neurol. 2022. PMID: 35737867 Free PMC article.
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.
De Keersmaecker AV, Van Doninck E, Popescu V, Willem L, Cambron M, Laureys G, D' Haeseleer M, Bjerke M, Roelant E, Lemmerling M, D'hooghe MB, Derdelinckx J, Reynders T, Willekens B. De Keersmaecker AV, et al. Among authors: d haeseleer m. Front Immunol. 2024 Feb 21;15:1362629. doi: 10.3389/fimmu.2024.1362629. eCollection 2024. Front Immunol. 2024. PMID: 38680485 Free PMC article.
63 results